The Maine Wire
  • News
  • Commentary
  • Maine Wire TV
  • Podcasts
  • About
  • Contact
Facebook Twitter Instagram
Trending News
  • Buxton Man Convicted by Federal Jury for Threats Against Jewish People on Twitter
  • Portland Police Report Pair of Incidents Where Men Attempted to Lure School-Aged Children Into Vehicles
  • King, Collins, Pingree Request DHS Rule Change to Help Fund Shelter and Services for Migrants
  • Your Choice of Automobile Will Soon be Controlled by Californians
  • Maine Man Faces up to 5 Years, $250,000 Fine for Making False Statements to DEA Officer
  • CMP’s Alleged “Excessive Spending” in 2022 at Center of Upcoming Maine PUC Hearings
  • The Supreme Court Case That Could Make the Taxation of Unrealized Income Unconstitutional
  • Maine Hospital CEO Threatens to Fire 500 Employees If They Don’t Get Flu Vaccine
Facebook Twitter Instagram
The Maine Wire
Login
Friday, December 8
  • News
  • Commentary
  • Maine Wire TV
  • Podcasts
  • About
  • Contact
The Maine Wire
Home » News » Bankrupt FTX Gave $18.2M to Early COVID-19 Researchers Who Cast Doubt on Ivermectin and Hydroxychloroquine
News

Bankrupt FTX Gave $18.2M to Early COVID-19 Researchers Who Cast Doubt on Ivermectin and Hydroxychloroquine

Steve RobinsonBy Steve RobinsonNovember 15, 2022Updated:November 17, 2022No Comments3 Mins Read
Facebook Twitter Email LinkedIn Reddit
Share
Facebook Twitter LinkedIn Email

Samuel Bankman-Fried’s bankrupt and scandal-plagued cryptocurrency empire gave $18.25 million to early COVID-19 researchers whose findings cast doubt on the benefits of ivermectin and hydroxychloroquine for patients with COVID-19.

The FTX Foundation provided initial funding worth $3.25 million and followed it with another $15 million grant, according to a press release issued May 16.

“The FTX Foundation is excited to commit $15 million to funding additional trial arms in the TOGETHER Trial and its growing global network of sister trials,” said Ross Rheingans-Yoo, from the FTX Foundation.

“Our initial $3.25 million grant to expand the trial network’s core infrastructure has helped bring the model from Brazil to key sites across the globe, and we look forward to finding further opportunities to support the consortium’s growth and help prevent future pandemics,” he said.

Together Trial’s research included a study that found ivermectin’s benefits for patients suffering from COVID-19 were unclear and a study that concluded hydroxychloroquine did not show any benefit in decreasing hospitalizations. Both studies were influential amid debates over the use of conventional, inexpensive treatments as opposed to expensive mRNA injections developed by the large pharmaceutical companies, like Pfizer, Moderna, and Johnson & Johnson.

[RELATED: Sam Bankman-Fried’s FTX Collapse Touches Ukraine, the World Economic Forum, Silicon Valley and Both Sides of D.C….]

Both drugs were floated early in the pandemic as potential treatments for those suffering from the virus, but they quickly became politically polarizing when they received support from President Donald Trump and podcaster Joe Rogan. Mainstream physicians and the media raced to discredit the cheap, safe drugs that have been used for decades for a host of other diseases. Both of these studies were led by Dr. Gilmar Reis.

Here’s a link to the study on ivermectin, which appeared in the New England Journal of Medicine in April 2022.

Here’s a link to the Sept. 2021 study on hydroxychloroquine.

Screenshots below:

The “Together Trial” research sponsored by FTX Foundation also study metformin and fluvoxamine. Under trial sponsors, the website list FTX, and FTX is the only sponsor listed on the organizations homepage.

A YouTube video posted by Trial Together has some of the same hallmarks as FTX and the now-defunct partner firm, Alameda Research. Namely, the claim that the group is using novel methods and complicated computer science to produce results that might not be available to ordinary researchers.

Here are the profile pictures for the organizations investigators:

Print Friendly, PDF & Email
COVID-19
Previous ArticleLet’s Give Another $37 Billion to Ukraine, says White House
Next Article Patten: Ukraine military aid is a good investment
Steve Robinson
  • Twitter

Steve Robinson is the Editor-in-Chief of The Maine Wire. ‪He can be reached by email at Robinson@TheMaineWire.com.

Related Posts

Buxton Man Convicted by Federal Jury for Threats Against Jewish People on Twitter

December 8, 2023

Portland Police Report Pair of Incidents Where Men Attempted to Lure School-Aged Children Into Vehicles

December 8, 2023

King, Collins, Pingree Request DHS Rule Change to Help Fund Shelter and Services for Migrants

December 8, 2023

Leave A Reply

Recent News

Buxton Man Convicted by Federal Jury for Threats Against Jewish People on Twitter

December 8, 2023

Portland Police Report Pair of Incidents Where Men Attempted to Lure School-Aged Children Into Vehicles

December 8, 2023

King, Collins, Pingree Request DHS Rule Change to Help Fund Shelter and Services for Migrants

December 8, 2023

Maine Man Faces up to 5 Years, $250,000 Fine for Making False Statements to DEA Officer

December 7, 2023

CMP’s Alleged “Excessive Spending” in 2022 at Center of Upcoming Maine PUC Hearings

December 7, 2023
Newsletter

News

  • News
  • Campaigns & Elections
  • Opinion & Commentary
  • Media Watch
  • Education
  • Media

Maine Wire

  • About the Maine Wire
  • Advertising
  • Contact Us
  • Submit Commentary
  • Complaints
  • Maine Policy Institute

Resources

  • Maine Legislature
  • Legislation Finder
  • Get the Newsletter
  • Maine Wire TV

Facebook Twitter Instagram Steam RSS
  • Post Office Box 7829, Portland, Maine 04112

Type above and press Enter to search. Press Esc to cancel.

Sign In or Register

Welcome Back!

Login below or Register Now.

Lost password?

Register Now!

Already registered? Login.

A password will be e-mailed to you.